The emerging roles of human tissue kallikreins in cancer

被引：524
作者：
Borgoño, CA [1 ]
Diamandis, EP [1 ]
机构：
[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
来源：
NATURE REVIEWS CANCER | 2004年 / 4卷 / 11期
关键词：
D O I：
10.1038/nrc1474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Human tissue kallikreins (hKs), which are encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiological roles. Although primarily known for their clinical applicability as cancer biomarkers, recent evidence implicates hKs in many cancer-related processes, including cell-growth regulation, angiogenesis, invasion and metastasis. They have been shown to promote or inhibit neoplastic progression, acting individually and/or in cascades with other hKs and proteases, and might represent attractive targets for therapeutic intervention.
引用
收藏
页码：876 / 890
页数：15
相关论文
共 198 条
  • [1] IMMUNOHISTOCHEMICAL DISTRIBUTION OF THE 3 PREDOMINANT SECRETORY PROTEINS IN THE PARENCHYMA OF HYPERPLASTIC AND NEOPLASTIC PROSTATE-GLANDS
    ABRAHAMSSON, PA
    LILJA, H
    FALKMER, S
    WADSTROM, LB
    [J]. PROSTATE, 1988, 12 (01) : 39 - 46
  • [2] Predicting biomarkers for ovarian cancer using gene-expression microarrays
    Adib, TR
    Henderson, S
    Perrett, C
    Hewitt, D
    Bourmpoulia, D
    Ledermann, J
    Boshoff, C
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (03) : 686 - 692
  • [3] A novel protease homolog differentially expressed in breast and ovarian cancer
    Anisowicz, A
    Sotiropoulou, G
    Stenman, G
    Mok, SC
    Sager, R
    [J]. MOLECULAR MEDICINE, 1996, 2 (05) : 624 - 636
  • [4] BARRETT AD, 2004, HDB PROTEOLYTIC ENZY, P1556
  • [5] Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA
    Barrou, B
    Benoît, GR
    Ouldkaci, M
    Cussenot, O
    Salcedo, M
    Agrawal, S
    Massicard, SV
    Bercovici, N
    Ericson, ML
    Thiounn, N
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (05) : 453 - 460
  • [6] Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation
    Bayés, A
    Tsetsenis, T
    Ventura, S
    Vendrell, J
    Aviles, FX
    Sotiropoulou, G
    [J]. BIOLOGICAL CHEMISTRY, 2004, 385 (06) : 517 - 524
  • [7] Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system
    Bernett, MJ
    Blaber, SI
    Scarisbrick, IA
    Dhanarajana, P
    Thomspon, SM
    Blaber, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) : 24562 - 24570
  • [8] Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter
    Bharaj, B
    Scorilas, A
    Diamandis, EP
    Giai, M
    Levesque, MA
    Sutherland, DJA
    Hoffman, BR
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2000, 61 (02) : 111 - 119
  • [9] Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast,testicular, and ovarian cancers
    Bharaj, BB
    Luo, LY
    Jung, K
    Stephan, C
    Diamandis, EP
    [J]. PROSTATE, 2002, 51 (01) : 35 - 41
  • [10] Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
    Bhattacharjee, A
    Richards, WG
    Staunton, J
    Li, C
    Monti, S
    Vasa, P
    Ladd, C
    Beheshti, J
    Bueno, R
    Gillette, M
    Loda, M
    Weber, G
    Mark, EJ
    Lander, ES
    Wong, W
    Johnson, BE
    Golub, TR
    Sugarbaker, DJ
    Meyerson, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13790 - 13795
12345678910